Related Experiment Video
Updated: May 5, 2026

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression
Published on: May 7, 2019
[Rheumatoid meningitis without arthritis presenting as widespread symmetrical high-intensity lesions along cerebral
Takanobu Kita1, Hiroaki Okada1, Seiji Takenouchi2
1Department of Neurology, Ichinomiya-Nishi Hospital.
Abstract:
A 52-year-old woman presented with the subacute onset of pantalgia, fever and consciousness disturbance. MRI revealed widespread symmetrical high-intensity areas along the sulci in both cerebral hemispheres on diffusion-weighted imaging (DWI). Rheumatoid meningitis was suspected based on elevated levels of anti-cyclic citrullinated peptide antibodies (ACPA) in both serum and cerebrospinal fluid (CSF), as well as an elevated ACPA index. Brain biopsy revealed marked infiltration of inflammatory cells in the subarachnoid space, confirming the diagnosis of rheumatoid meningitis. The patient fully recovered after receiving six courses of steroid pulse therapy, followed by postremission therapy. Diagnosing cases without arthritis can be challenging, but testing for ACPA and evaluating the ACPA index can be useful for both diagnosis and assessing therapeutic efficacy in cases of suspected rheumatoid meningitis.
Insights
Rheumatoid meningitis, a rare condition, can be diagnosed using anti-cyclic citrullinated peptide antibodies (ACPA) levels, even without arthritis. Testing ACPA and the ACPA index aids diagnosis and treatment monitoring.
Area of Science:
- Neurology
- Rheumatology
- Immunology
Background:
- Rheumatoid meningitis is an uncommon neurological complication of rheumatoid arthritis.
- Diagnosis can be challenging, particularly in patients without overt arthritis.
- Cerebral involvement in rheumatoid arthritis necessitates accurate diagnostic markers.
Purpose of the Study:
- To investigate the utility of anti-cyclic citrullinated peptide antibodies (ACPA) in diagnosing rheumatoid meningitis.
- To evaluate the ACPA index in serum and cerebrospinal fluid (CSF) for diagnostic and therapeutic assessment.
- To highlight a case of rheumatoid meningitis successfully treated with immunotherapy.
Main Methods:
- Case presentation of a 52-year-old woman with neurological symptoms.
- Magnetic Resonance Imaging (MRI) with diffusion-weighted imaging (DWI) for neuroimaging.
- Analysis of serum and CSF for anti-cyclic citrullinated peptide antibodies (ACPA) and calculation of the ACPA index.
- Brain biopsy for histopathological confirmation.
- Treatment with high-dose corticosteroids (steroid pulse therapy) and subsequent maintenance therapy.
Main Results:
- MRI revealed characteristic symmetrical high-intensity lesions in the cerebral hemispheres on DWI.
- Elevated ACPA levels in serum and CSF, along with an elevated ACPA index, supported the diagnosis.
- Brain biopsy confirmed inflammatory cell infiltration in the subarachnoid space, indicative of rheumatoid meningitis.
- The patient achieved full recovery following immunotherapy.
Conclusions:
- Anti-cyclic citrullinated peptide antibodies (ACPA) testing and ACPA index evaluation are valuable tools for diagnosing rheumatoid meningitis, especially in non-arthritic patients.
- These immunological markers can aid in assessing therapeutic efficacy.
- Prompt diagnosis and appropriate treatment, such as steroid pulse therapy, lead to favorable outcomes in rheumatoid meningitis.
Related Concept Videos
Viral Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Brain Abscess l: Introduction
Multiple Sclerosis l: Introduction

